H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019

About This Bill

Bill Sponsor

Bill Cosponsor

Bill Version

Bill Summary

Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 This bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated from natural sources. A biosimilar version is substantially similar to the original biologic,...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 6 statements associated with H.R.3991.

Bill Actions

Date Description
Nov. 21, 2019
Ordered to be Reported (Amended).
Nov. 21, 2019
Committee Consideration and Mark-up Session Held.
Nov. 19, 2019
Subcommittee on Courts, Intellectual Property, and the Internet Discharged.
Aug. 28, 2019
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
July 25, 2019
Referred to the House Committee on the Judiciary.
July 25, 2019

Introduced in the House by Hank Johnson (D-Ga.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page